LVZ Inc’s AbbVie ABBV Stock Holding History

LVZ Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$290K	Buy	1,151 +21	+2%	+$4.52K	0.03%	141
2026 Q1	$246K	Sell	1,130 -110	-9%	-$24.4K	0.03%	132
2025 Q4	$283K	Buy	+1,240	New	+$282K	0.03%	132

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

LVZ Inc's ABBV Position: Q2 2026 in Review

LVZ Inc increased its AbbVie (ABBV) stake by 1.9% in Q2 2026, buying an estimated $4.52K and bringing the position to 1,151 shares worth $290K. The position accounts for 0.03% of the portfolio, ranked #141.

LVZ Inc first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. 1,766 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

LVZ Inc held 1,151 shares of AbbVie worth $290K as of Q2 2026.
LVZ Inc bought 21 AbbVie shares in Q2 2026, an estimated $4.52K.
AbbVie made up 0.03% of LVZ Inc's portfolio in Q2 2026, its #141 holding.
LVZ Inc first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
1,766 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on LVZ Inc's 13F filing for Q2 2026, filed 9 Jul 2026.